Application Diversity and End-User Requirements: Segmentation Across Therapeutic Areas in the Biosimulation Market Segment
  The segmentation of the Biosimulation Market segment is primarily defined by application area and the type of end-user, reflecting the varying complexity and regulatory requirements of different therapeutic domains. By application, the market is broadly divided into modeling for Pharmacokinetic/Pharmacodynamic (PK/PD) studies, Physiologically Based Pharmacokinetic (PBPK) modeling,...
0 Reacties 0 aandelen 18 Views 0 voorbeeld